Patent · US Active

IBAT inhibitors for the treatment of liver diseases

US10093697B2 · kind B2 · utility

20Cited by

34References

8Claims

0Family size

Assignee

ALBIREO AB · SE

Inventors

Per-Göran Gillberg · Timrå, SE
Hans Graffner · Helsingborg, SE
Ingemar Starke · Gothenburg, SE

Key dates

Filing date	Oct 5, 2017
Grant date	Oct 9, 2018
Priority date	—
Expiry date	Oct 5, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2121/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.